NEW ORLEANS – Gabapentin plus standard therapy produced results similar to those of placebo plus standard therapy.
News from the FDA/CDC
Officials at the Centers for Disease Control and Prevention are advising against misapplication of the agency’s guideline on opioid prescribing....
The use of extended half-life clotting factors was able to significantly reduce the number of infusions but the cost went up significantly.
Emicizumab was effective as a monthly treatment for patients with hemophilia A, both with and without inhibitors, according to an ongoing phase 3...
NEWPORT BEACH, CALIF. – Researchers identified transgender leukemia patients by detecting gender-karyotype mismatches.
SILVER SPRING, MD. – Women report personal horror stories of apparent breast-implant complications, but systematically-collected data remain...
NEW ORLEANS – Dropping aspirin but keeping anticoagulation with apixaban and antiplatelet clopidogrel was effective and associated with less...
HONOLULU – The drug establishes good or excellent hemostasis in 82% of patients with acute major bleeding associated...
SEATTLE – Two studies detail the risk factors of first-time venous thromboembolism and heightened incidence of repeat VTE in patients with HIV.
PRAGUE – The biggest question for gene therapy today is durability, according to Dr. John Pasi.